UK markets closed

Amedisys, Inc. (AMED)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
96.50+0.37 (+0.38%)
As of 11:46AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 3.14B
Enterprise value 3.51B
Trailing P/E 23.79
Forward P/E 21.23
PEG ratio (5-yr expected) 1.35
Price/sales (ttm)1.40
Price/book (mrq)2.89
Enterprise value/revenue 1.56
Enterprise value/EBITDA 28.75

Trading information

Stock price history

Beta (5Y monthly) 0.84
52-week change 322.15%
S&P500 52-week change 328.04%
52-week high 396.60
52-week low 374.61
50-day moving average 392.69
200-day moving average 393.32

Share statistics

Avg vol (3-month) 3284.33k
Avg vol (10-day) 3300.41k
Shares outstanding 532.68M
Implied shares outstanding 632.68M
Float 832.03M
% held by insiders 12.30%
% held by institutions 193.27%
Shares short (30 Apr 2024) 42.31M
Short ratio (30 Apr 2024) 411.17
Short % of float (30 Apr 2024) 47.18%
Short % of shares outstanding (30 Apr 2024) 47.06%
Shares short (prior month 28 Mar 2024) 42.49M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 24:3
Last split date 305 Dec 2006

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -0.92%
Operating margin (ttm)9.15%

Management effectiveness

Return on assets (ttm)6.26%
Return on equity (ttm)-1.87%

Income statement

Revenue (ttm)2.25B
Revenue per share (ttm)69.00
Quarterly revenue growth (yoy)2.70%
Gross profit (ttm)N/A
EBITDA 226.54M
Net income avi to common (ttm)-20.59M
Diluted EPS (ttm)-0.64
Quarterly earnings growth (yoy)-43.00%

Balance sheet

Total cash (mrq)108.23M
Total cash per share (mrq)3.31
Total debt (mrq)481.82M
Total debt/equity (mrq)42.17%
Current ratio (mrq)1.09
Book value per share (mrq)33.30

Cash flow statement

Operating cash flow (ttm)104.69M
Levered free cash flow (ttm)243.26M